Karuna Therapeutics, Inc.
http://www.karunatx.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Karuna Therapeutics, Inc.
ARCH Cites Stability Of Long-Term Investors In Raising $3bn Fund
ARCH Venture Partners brought in $2.975bn for its latest fund to give additional long-term investors a place at the table as the VC firm creates, builds and supports new early-stage biotechnology start-ups.
Fears For Ukraine’s Access To Medicines And Trials As Russian Invasion Continues
The European pharma sector is looking to maintain supplies of essential medicines to Ukraine and Russia as invasion continues, while a US biopharma group is calling for industries to boycott all non-food and medical trade with Russia.
Fears For Ukraine’s Access To Medicines And Trials As Russian Invasion Continues
The European pharma sector is looking to maintain supplies of essential medicines to Ukraine and Russia as invasion continues while a US biopharma group is calling for industry to boycott all non-food and medical trade with Russia.
Cerevel Makes Progress, But Karuna Still One To Watch In Schizophrenia
Competition to bring new schizophrenia therapies to market is increasing, with the need to demonstrate side-effect improvements over existing drugs especially important.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals